After Berlin and Leipzig, the next stop for Invisio: Salzburg. Invisio’s Chief Executive Officer Florian Schnabel and Clinical Project Manager Dr. Christina Gehbauer will be visiting the DACH Symposium on Clinical Trials in the Austrian city from May 30–31. Invisio is supporting the thee-country congress as a roll-up sponsor.
What is Florian Schnabel looking forward to most? The professional input of the speakers and the personal exchanges. “We’ve had many video conferences over the past two years. That was a good alternative for staying in contact with business partners in a way that complied with Covid-19 restrictions. But now we’re pleased that we can have fruitful discussions in person and on site once again.” The CEO would like to lead these discussions with sponsors and players from the medical technology, biotechnology, and pharmacy sectors, among others. But also with study staffs and clinical research associates. “Not only have we successfully survived the coronavirus pandemic,” says Florian Schnabel, “but we’ve actually grown throughout Europe, and we plan on continuing this growth. The DACH Symposium offers us the chance to find exciting collaborators for interesting projects.”
In Salzburg, Florian Schnabel will also be spreading the word on the start-up ClinCoach, which he cofounded. Its portfolio includes digital training for clinical staff (including GCP online courses), standardized self-teaching offers, and custom-fit online courses for pharmaceutical customers.
Will you be in Salzburg too at the end of May? Then we’ll look forward to hearing from you.
If you would like to learn more about Invisio and its services, please feel free to make an appointment in advance with Florian Schnabel and/or Dr. Christina Gehbauer.
To do so, please write an email to info@invisio.eu
or call the following number +49 (0)621 / 180 685 940
